Source: MarketScreener

Leap Therapeutics: Leap Therapeutics : Expands Leadership Team with Addition of Two Industry Veterans

(marketscreener.com) CAMBRIDGE, Mass., Aug. 24, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. , a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced the expansion of its leadership team with the appointment of Jason S. Baum, Ph.D., as Vice President, Head of Translational Medicine and Christine M. Granfield as Vice...https://www.marketscreener.com/quote/stock/LEAP-THERAPEUTICS-INC-33375941/news/Leap-Therapeutics-Expands-Leadership-Team-with-Addition-of-Two-Industry-Veterans-31165719/?utm_medium=RSS&utm_content=20200824

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Employees
Chris Mirabelli's photo - CEO of Leap Therapeutics

CEO

Chris Mirabelli

CEO Approval Rating

73/100

Leap Therapeutics researches, develops and commercializes monoclonal antibodies that enable immune system to identify and attack cancer cells. Read more